Schedule 13G ownership disclosure

Rich Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 76303T209

Event date: 2015-02-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001398344-15-001093
Form type
SC 13G
Filer
Rich Pharmaceuticals, Inc.
CIK
CIK 1504389
Filed
Feb 18, 2015
Reporting period
Feb 17, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub